SP1 and neoplasm: The synergistic anti-tumor effect of SP1 inhibitor and TEAD inhibitor was also observed by using a newly developed pan-TEAD inhibitor of TEAD auto-palmitoylation, VT107 [41] (Supplementary S4B–F).